Orchid Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Orchid Pharma Ltd · Outcome · 14 Nov 2026, 9:45 pm
Orchid Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 34,127 (+14.3% YoY | +12.2% QoQ) ■ EBITDA: 2,414 (+682.6% YoY | +72.4% QoQ) ■ EBITDA Margin (%): 7.1 (+604 bps YoY | +247 bps QoQ) ■ PAT: 2,859 (Loss to Profit YoY | +786.8% QoQ) ■ EPS (INR): 4.77 (Loss to Profit YoY | +783.3% QoQ)
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') · 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges · 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 · 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) · 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 · 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 · 14 Nov 2026
- Intimation of schedule of Analysts/ Investors Earning Call for the Ouarter-II of F.Y. 2026-27 ended on September 30, 2026 · 17 Nov 2026
